ASCVD Risk Calculator

Free ASCVD risk calculator using the 2013 Pooled Cohort Equations. Estimate your 10-year heart attack and stroke risk, heart age, lifetime risk, and what-if scenarios for risk reduction.

The PCE was developed using White and African American cohorts. For other ethnicities, the White coefficients are used as the closest approximation.

Top number from your BP reading

Risk Factors

Who should use this? Adults aged 40–79 without existing cardiovascular disease, with LDL-C < 190 mg/dL, and not currently on lipid-lowering therapy. If any of these apply to you, discuss risk assessment with your clinician instead.

10-Year ASCVD Risk

5.4%

Borderline Risk
5.4%
<5%
5–7.5%
7.5–20%
≥20%

Your 10-year ASCVD risk is 5–7.5%. Discuss risk-enhancing factors with your clinician.

Key Metrics

Heart age, optimal benchmark, and lifetime risk at a glance

Heart Age

59yrs

+4 vs actual age

Lifetime Risk*

46%

*For a 50-year-old with your risk profile

Optimal Risk

3.6%

10-Year Risk

5.4%

What If You Changed...

See how modifying risk factors could reduce your 10-year risk

Reduce SBP by 10 mmHg
4.6%0.7% (14% reduction)
Optimal Cholesterol
4.4%0.9% (18% reduction)

Toggle smoking or diabetes inputs to see additional what-if scenarios.

ASCVD Risk Categories

2013 ACC/AHA guideline thresholds for statin therapy discussion

Low Risk< 5%
Borderline Risk5 – 7.5%
Intermediate Risk7.5 – 20%
High Risk≥ 20%

Source: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk (Goff et al., Circulation 2014).

What Is ASCVD?

Understanding atherosclerotic cardiovascular disease

Atherosclerotic cardiovascular disease (ASCVD) is caused by plaque buildup in artery walls. It is the leading cause of death worldwide — approximately 17.9 million deaths per year (WHO).

Coronary DiseaseHeart attacks, angina
StrokeIschemic stroke, TIA
Peripheral ArteryReduced limb blood flow
Aortic DiseasePlaque in the aorta
Why calculate your risk? The 10-year ASCVD risk score estimates the probability of a first heart attack or stroke within the next decade. Clinicians use this score to guide statin therapy, lifestyle modifications, and monitoring frequency.

How to Use This Calculator

5 steps to estimate your cardiovascular risk

1

Enter Demographics

Age (40–79), biological sex, and race/ethnicity. The equations use sex- and race-specific statistical models.

2

Enter Cholesterol

Total cholesterol and HDL-C from a lipid panel blood test. Toggle between mg/dL and mmol/L units.

3

Enter Blood Pressure

Systolic BP (top number) and whether you're on antihypertensive medication.

4

Toggle Risk Factors

Indicate diabetes status and current smoking status.

5

Review Results

See your 10-year risk, heart age, and what-if scenarios for risk reduction. For ages 40–59, a lifetime risk estimate is also shown.

Tip: Use the "What If" scenarios to see how quitting smoking, lowering blood pressure, or managing cholesterol could reduce your risk.

The Pooled Cohort Equations (PCE)

The validated statistical model powering this calculator

Published in 2013 by the ACC/AHA, the PCE uses Cox proportional hazards regression from four landmark cohort studies:

ARIC

Atherosclerosis Risk in Communities

CARDIA

Coronary Artery Risk Development

CHS

Cardiovascular Health Study

FHS

Framingham Heart Study

9 inputs across 4 sex/race-specific models:

Age
Sex
Race
Total Chol.
HDL-C
Systolic BP
BP Meds
Diabetes
Smoking

Formula

Risk = 1 − S₀exp(ΣβᵢXᵢ − μ)

S₀ = baseline 10-year survival  |  βᵢ = regression coefficients  |  Xᵢ = ln-transformed risk factors  |  μ = population mean

Reference: Goff DC Jr, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. Circulation 2014;129(25 Suppl 2):S49–S73.

ASCVD Risk Categories & Actions

ACC/AHA guideline thresholds for preventive therapy

< 5%Low Risk

Continue healthy lifestyle. Statins generally not recommended unless risk-enhancing factors present (family history of premature ASCVD, LDL-C ≥ 160).

5 – 7.5%Borderline

Discuss risk-enhancing factors: family history, metabolic syndrome, elevated CRP or Lp(a), South Asian ancestry. Consider CAC scoring.

7.5 – 20%Intermediate

A clinician-patient discussion about moderate-intensity statin therapy is reasonable. CAC scoring can help guide the decision — a CAC of 0 may favor deferral.

≥ 20%High Risk

A clinician-patient discussion about statin therapy is strongly recommended. The intensity and any additional therapies should be individualized based on your full clinical profile.

How to Reduce Your ASCVD Risk

Evidence-based strategies with quantified impact

Quit Smoking25–30%

Risk begins dropping within weeks. Equals non-smoker risk within 5–15 years.

Control Blood Pressure20–25%

Target < 130/80 mmHg. Each 10 mmHg SBP drop lowers risk significantly.

Manage Cholesterol25–35%

Statins first-line. Every 39 mg/dL LDL-C reduction lowers risk ~22%.

Manage Diabetes15–20%

Target HbA1c < 7%. SGLT2i and GLP-1a have proven cardiovascular benefits.

Regular Exercise20–30%

150+ min/week moderate-intensity aerobic activity per AHA guidelines.

Healthy Diet10–20%

Mediterranean or DASH diet. Emphasize fruits, vegetables, whole grains, fish.

Risk reduction percentages are approximate ranges from published clinical trials and meta-analyses. Individual results vary based on baseline risk, age, and adherence.

Statin Therapy Quick Guide

Dosing intensity based on your ASCVD risk level

IntensityLDL-C ReductionExamples
High
≥ 50%Atorvastatin 40–80 mg, Rosuvastatin 20–40 mg
Moderate
30–49%Atorvastatin 10–20 mg, Rosuvastatin 5–10 mg, Simvastatin 20–40 mg
Low
< 30%Simvastatin 10 mg, Pravastatin 10–20 mg, Lovastatin 20 mg
2018 ACC/AHA Guidance: For primary prevention without existing ASCVD, statin intensity is a shared decision between clinician and patient. Risk ≥ 7.5% generally warrants discussion; risk-enhancing factors and CAC scoring further guide the decision. This table is for educational reference only.

Limitations & Important Notes

What this calculator can and cannot tell you

Age range

Validated for ages 40–79 without pre-existing ASCVD. For younger adults, consider lifetime risk. For 80+, use clinical judgment.

Race & ethnicity

Specific models for White and African American populations. For Hispanic, Asian, or other groups, White coefficients are used — may be less accurate. The 2023 PREVENT model is race-agnostic.

Potential overestimation

Studies (MESA, Rotterdam) suggest PCE may overestimate risk by 20–60% in some groups. CAC scoring can reclassify up to 50% of intermediate-risk patients.

Missing factors

Does not account for family history, BMI, kidney function (eGFR), inflammatory markers (CRP), lipoprotein(a), or South Asian ancestry.

Medical disclaimer: This calculator is an educational tool based on the 2013 ACC/AHA Pooled Cohort Equations. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for cardiovascular risk assessment and treatment decisions.

Frequently Asked Questions

Common questions and detailed answers

Embed ASCVD Risk Calculator

Add this calculator to your website or blog for free.